Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.

Kurbel, Sven

Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. [electronic resource] - Medical hypotheses 2005 - 1182-7 p. digital

Publication Type: Comparative Study; Journal Article

0306-9877

10.1016/j.mehy.2004.09.026 doi


Breast Neoplasms--chemistry
Carcinoma, Ductal, Breast--chemistry
Cell Death
Cell Transformation, Neoplastic
Clone Cells--drug effects
Female
Humans
Mammary Glands, Human--chemistry
Models, Biological
Mosaicism
Neoplasm Proteins--analysis
Neoplasms, Hormone-Dependent--etiology
Neoplastic Stem Cells--drug effects
Receptors, Estrogen--analysis
Selection, Genetic
Selective Estrogen Receptor Modulators--pharmacology